PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002 trial

Stock Information for PDS Biotechnology Corporation

Loading

Please wait while we load your information from QuoteMedia.